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Abstract
Highly pathogenic H5N1 influenza A viruses have spread across Asia, Europe, and Africa. More than 500 cases of H5N1 virus
infection in humans, with a high lethality rate, have been reported. To understand the molecular basis for the high virulence
of H5N1 viruses in mammals, we tested the virulence in ferrets of several H5N1 viruses isolated from humans and found A/
Vietnam/UT3062/04 (UT3062) to be the most virulent and A/Vietnam/UT3028/03 (UT3028) to be avirulent in this animal
model. We then generated a series of reassortant viruses between the two viruses and assessed their virulence in ferrets. All
of the viruses that possessed both the UT3062 hemagglutinin (HA) and nonstructural protein (NS) genes were highly
virulent. By contrast, all those possessing the UT3028 HA or NS genes were attenuated in ferrets. These results demonstrate
that the HA and NS genes are responsible for the difference in virulence in ferrets between the two viruses. Amino acid
differences were identified at position 134 of HA, at positions 200 and 205 of NS1, and at positions 47 and 51 of NS2. We
found that the residue at position 134 of HA alters the receptor-binding property of the virus, as measured by viral elution
from erythrocytes. Further, both of the residues at positions 200 and 205 of NS1 contributed to enhanced type I interferon
(IFN) antagonistic activity. These findings further our understanding of the determinants of pathogenicity of H5N1 viruses in
mammals.
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Introduction
In 1997, the first human case of influenza caused by an H5N1
virus occurred in Hong Kong [1,2]. In 2003, a new outbreak of
H5N1 virus was identified in Vietnam. Since then, H5N1 viruses
have spread across Asia, Europe and Africa. As of July 22, 2010,
501 cases of H5N1 virus infections in humans have been reported
by the World Health Organization (WHO; http://www.who.int/
en/), 297 of which were fatal. The mortality is, therefore,
approximately 60%. H5N1 viruses have been characterized by
using a variety of mammalian models [3]. In mice, enhanced HA
cleavability, as well as lysine at position 627 of the polymerase
subunit PB2, plays an important role in the virulence of H5N1
viruses [4]. Viruses possessing these properties replicate systemi-
cally and cause death in mice.
Ferrets are considered suitable for evaluating infection of
human influenza viruses because these viruses replicate in the
upper respiratory tract without adaptation in ferrets, and some
strains cause severe pneumonia in these animals. Some of the
H5N1 viruses isolated from humans can kill ferrets, whereas
H5N1 viruses isolated from birds tend to cause mild disease in this
animal model [5,6]. Systemic infection, high replication efficien-
cies, and neurovirulence are associated with the high lethality of
human H5N1 viruses in ferrets. Salomon et al. [7] reported that
the genes encoding the nonstructural proteins (NS) and polymer-
ase complex are important for the lethality of the human H5N1
virus A/Vietnam/1203/04 in ferrets, compared with the avian
H5N1 virus A/quail/Vietnam/36/04. However, the molecular
bases for the high virulence of H5N1 viruses in ferrets are not fully
understood. To advance our understanding of the pathogenicity of
PLoS Pathogens | www.plospathogens.org 1 September 2010 | Volume 6 | Issue 9 | e1001106H5N1 viruses, we compared the virulence of H5N1 influenza
viruses isolated from humans in a ferret model. By generating
reassortant viruses between the most virulent A/Vietnam/
UT3062/04 (UT3062) virus and the avirulent A/Vietnam/
UT3028/03 (UT3028) virus, we identified the genes responsible
for high virulence in ferrets. We also performed in vitro studies to
determine the molecular mechanisms by which H5N1 viruses
exhibit high virulence in mammals.
Results
Virulence of Human H5N1 Influenza Viruses in Ferrets
To compare the virulence of H5N1 influenza viruses isolated
from humans in ferrets, we intranasally inoculated 5- to 7-month-
old male animals (n=3) with 10
7 plaque-forming units (PFU) of
virus and observed the lethality, changes in body weight and body
temperature, clinical signs, and virus shedding in the upper
respiratory tract of the virus-infected animals (Table 1). The
UT3062, A/Vietnam/UT3040/04, A/Vietnam/UT3028II/03,
A/Vietnam/UT30850/05, A/Vietnam/UT3030/03, A/Viet-
nam/UT3040II/04, and A/Vietnam/UT3047III/04 were viru-
lent in ferrets, causing the deaths of the virus-infected animals.
These virulent viruses, with the exception of A/Vietnam/
UT3028II/03, caused mean maximum weight loss of 9.1%–
18.4% and anorexia, consistent with previous studies [5,6].
Systemic viral infection was observed in most of the fatally
infected animals (Table S1). Notably, inoculation of animals with
UT3062 resulted in 100% lethality with 15.462.7% mean
maximum weight loss (Table 1). These results demonstrate that
UT3062 is the most virulent in ferrets of the viruses we tested.
By contrast, six other human H5N1 viruses, A/Vietnam/
UT30259/04, A/Vietnam/UT3035/03, A/Indonesia/UT3006/
05, UT3028, A/Vietnam/UT30408III/05, and A/Vietnam/
UT30262III/04 did not kill any ferrets and all, except A/
Vietnam/UT30259/04, caused limited body weight loss (1.6%–
6.6% mean maximum weight loss, median 4.2%) (Table 1),
indicating that H5N1 viruses isolated from humans differ in their
virulence in ferrets. Among the H5N1 viruses listed in Table 1,
two viruses, A/Vietnam/UT3035/03 and A/Vietnam/
UT30408III/05, which did not kill any ferrets, were isolated
from patients who recovered from their H5N1 virus infections.
The rest of the viruses used were isolated from patients who
ultimately died. Of note, the virulence of test viruses in ferrets
generally correlated with that in mice [8].
On days 3 and 6 post-infection (p.i.), we collected nasal washes
from the virus-infected animals and titrated them in Madin-Darby
canine kidney (MDCK) cells. On day 6 p.i., the virus titers in the
nasal washes of animals infected with the virulent viruses (except
for A/Vietnam/UT3028II/03) were generally higher than those
of animals infected with viruses that were not lethal (Table 1).
Generation of UT3062 and UT3028 by Reverse Genetics
Sequence comparisons of the viruses used in this study revealed
that the most virulent virus UT3062 was most closely related to an
avirulent virus UT3028, with 18 amino acid differences in their 9
proteins (Table S2); there were no amino acid differences in the
matrix (M) proteins of the two viruses. Therefore, we generated
UT3062 and UT3028 by reverse genetics and confirmed their
virulence by intranasally inoculating 5- to 6-month-old male
ferrets with 10
7 PFU of the viruses. Animals infected with the
UT3062 virus died on days 6–8, resulting in 67% lethality and
showed 213.463.1% mean maximum weight loss (Figures 1 and
2). Conversely, all animals infected with the UT3028 virus
survived and showed appreciably less mean maximum weight loss
(21.160.3%) (Figures 1 and 2). These results were similar to those
obtained with the respective original viruses (Figure 2 and Table 1).
Contributions of the HA and NS Genes to the Virulence of
UT3062 in Ferrets
To determine the molecular basis for the high virulence of
UT3062, we generated reassortant viruses between the UT3062
and UT3028 viruses using reverse genetics and tested their
virulence by intranasally inoculating 5- to 6-month-old male
ferrets with 10
7 PFU of the viruses and observing them for 10 days
for clinical manifestations. Since no amino acid differences were
identified in M proteins of the two viruses, we used the UT3028 M
gene for generating all reassortant viruses. The reassortants were
named according to the origin of their UT3062 or UT3028 genes.
For example, 3062(Pol+NP+HA+NA) indicates a virus possessing
the polymerase complex (PB1, PB2, and PA), nucleoprotein (NP),
HA, and neuraminidase (NA) genes from UT3062 and the rest of
its genes from UT3028 (Figure 2). Reassortant viruses possessing
both the UT3062 HA and NS genes, 3062(NP+HA+NA+NS),
3062(Pol+HA+NA+NS), 3062(HA+NA+NS), 3062(HA+NS), and
3062(NP+HA+NS), were lethal to animals (33%–100% lethality).
By contrast, those possessing either the HA or NS genes of
UT3028 were not lethal to any animals. Mean maximum body
weight loss in the animals infected with the former viruses (8.5%–
14.4%, median 11.4%) tended to be greater than that in the
animals infected with the latter viruses (0.7%–8.6%, median
4.1%). Animals infected with 3062(HA+NS) resulted in 83%
lethality and 17.8%62.7% mean maximum weight loss. These
results show that the difference in virulence between UT3062 and
UT3028 is mainly attributable to both of the HA and NS genes.
Sequence comparison between UT3062 and UT3028 revealed
only one amino acid difference in their HA proteins and four
amino acid differences in their NS proteins, two in NS1 and two in
NS2 (Table 2). Since NS1 and NS2 mRNAs are produced from
the same gene segment, with the NS1 mRNA being unspliced and
the NS2 mRNA being spliced, the nucleotide alterations can affect
both proteins; i.e., the amino acid differences at positions 200 and
205 of NS1 were coupled to those at positions 47 and 51 of NS2,
respectively. Therefore, it was impossible to substitute the amino
acids only in the NS1 or the NS2 protein. Here, we generated two
reassortant viruses with a mutation in the NS segment by reverse
genetics. 3062(HA)+NS1N200S possesses the UT3062 HA gene, a
Author Summary
Highly pathogenic H5N1 influenza A viruses have caused
more than 500 human infections with approximately 60%
lethality in 15 countries and continue to pose a pandemic
threat. The recent worldwide spread of pandemic H1N1
influenza A viruses raises the concern of reassortment
between the H5N1 viruses and other influenza viruses.
However, the molecular determinants for high virulence of
the H5N1 viruses in mammals are not fully understood.
We, therefore, investigated their virulence in a ferret
model, which is a widely accepted animal model for
assessing human influenza virus replication. We identified
an amino acid in hemagglutinin and four amino acids in
nonstructural proteins that are associated with high
virulence of a human H5N1 virus, A/Vietnam/UT3062/04.
We also found that the amino acid in hemagglutinin
changes its receptor-binding property and the amino acids
in nonstructural protein 1 affect its interferon antagonistic
ability. These findings provide insight into the pathogen-
esis of H5N1 viruses in mammals.
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has an asparagine-to-serine substitution at position 200 (and
encodes NS2 with a threonine-to-alanine substitution at position
47) and the rest of its genes from UT3028. 3062(HA)+NS1G205R
possesses the UT3062 HA gene, a mutant NS segment encoding
the UT3028 NS1 protein, which has glycine-to-arginine substitu-
tion at position 205 (and encodes NS2 with a methionine-to-
isoleucine substitution at position 51) and the rest of its genes from
UT3028. We then tested their virulence in ferrets as described
above. As shown in Figure 2, both of the reassortant viruses,
3062(HA)+NS1N200S and 3062(HA)+NS1G205R, were not
lethal to any animals, with 4.8%61.4% and 2.3%61.4 mean
maximum weight loss, respectively. These results suggest that all of
the amino acids in HA and NS proteins contribute to the virulence
in ferrets, although it is unclear whether changes in NS1, NS2, or
both affect virulence.
In addition, 3062(HA+NA+NS) (33% lethality and 8.563.4%
mean maximum body weight loss) was attenuated compared to
3062(NP+HA+NA+NS) (67% lethality and 14.464.9% mean
maximum body weight loss). Further, 3062(NP+HA+NS) and
3062 (HA+NS) killed 100% and 83% of animals, respectively.
These results suggest that the UT3062 NP gene may enhance
virus virulence in ferrets. These results are consistent with
previous findings that virulence of influenza virus is multigenic
[7,9,10].
Viral Replication in Ferrets and Cell Culture
To understand the basis for the difference in virulence in
ferrets among the viruses, we examined the in vitro and in vivo
replication of the parental UT3062, UT3028, and the
reassortant viruses. For in vitro testing, we compared their
growth kinetics in mink lung epithelial (Mv1Lu) cells by infecting
these cells with viruses at a multiplicity of infection (MOI) of
0.001 and monitoring the growth kinetics for 48 h. All of the
viruses replicated to more than 10
8 PFU/ml at 36 or 48 h p.i.
and the differences in their viral titers were less than one log
PFU/ml at each time point (Figure S1), indicating that there
were no substantial differences in their replicative ability in these
cells.
To examine viral replication in ferrets, we infected animals with
10
7 PFU of the parental UT3062, UT3028, and selected
reassortant viruses (3062(HA+NS), 3062(NP+HA+NS), and
3062(HA+NA+NS)). Virus titers in nasal and tracheal swabs,
and organs were examined. On days 3 and 7 p.i., three animals
from each infected group were sacrificed for virus titration. As
shown in Table 3, UT3062, 3062(HA+NS), 3062(NP+HA+NS),
and 3062(HA+NA+NS) were detected systemically on days 3 and
7 p.i., whereas UT3028 was detected mainly in the upper
respiratory tracts of ferrets on day 3, but not 7, p.i. The differences
in replicative ability of these viruses in ferrets thus correlate with
lethality in this animal model.
Tissue Pathology in Ferrets
When we compared the histopathology between ferrets infected
with UT3062 and those infected with UT3028, we found three
major differences (Figures 3 and 4): (1) host reaction to viral
exposure in the lungs on day 1 p.i., (2) viral infection in the
tracheobronchial lymph node, and (3) distribution of viral antigens
and the inflammatory reaction in the lungs on day 3 and beyond
p.i. Firstly, cells infiltrating the lung lesions differed between
Table 1. Virulence of H5N1 influenza viruses in ferrets.
Virus
No. of
dead/total
Day of
death
a
Virus shedding in nasal
washes on indicated
day p.i. (log10)
b Clinical signs
36
Weight
change (%)
e
Temperature
increase (uC)
e
Neurological
signs
f Anorexia
f
A/Vietnam/UT3062/04 3/3 6,6,8 4.760.5 2.160.5 215.462.7 2.060.4 0/3 3/3
A/Vietnam/UT3040/04 2/3 6,9 4.560.2 2.7, -
c 213.663.7 2.560.1 3/3 3/3
A/Vietnam/UT3028II/03 2/3 4,5 4.261.1 -
d 25.866.7 2.260.6 0/3 1/3
A/Vietnam/UT30850/05 1/3 7 3.660.3 2.661.8 218.462.1 2.160.2 1/3 3/3
A/Vietnam/UT3030/03 1/3 7 4.660.3 2.1, 1.5, - 212.065.2 2.560.4 2/3 2/3
A/Vietnam/UT3040II/04 1/3 7 4.460.5 4.2, -,- 210.564.0 2.860.3 1/3 2/3
A/Vietnam/UT3047III/04 1/3 8 3.660.3 1.8, 1.0, - 29.163.6 2.360.4 1/3 3/3
A/Vietnam/UT30259/04 0/3 - 3.362 . 0 - ,- ,- 212.366.7 1.760.1 0/3 3/3
A/Vietnam/UT3035/03 0/3 - 2.660.2 1.8, -,- 26.665.7 2.160.3 0/3 0/3
A/Indonesia/UT3006/05 0/3 - 4.760 . 7 - ,- ,- 25.262.5 2.360.3 2/3 1/3
A/Vietnam/UT3028/03 0/3 - 3.860 . 4 - ,- ,- 24.861.7 2.060.5 0/3 2/3
A/Vietnam/UT30408III/05 0/3 - NA NA 23.061.4 1.660.7 0/3 0/3
A/Vietnam/UT30262III/04 0/3 - NA NA 21.660.9 0.760.5 0/3 0/3
aFerrets were infected with 10
7 PFU of virus in 0.5 ml. Any ferrets exhibiting hemorrhage from a body orifice or the inability to remain upright were euthanized under
deep anesthesia.
bNasal washes were collected from ferrets on days 3 and 6 post-infection and titrated in MDCK cells. Mean titers, expressed as log10 PFU/ml with standard deviations, are
shown. When virus was not recovered from all ferrets, individual titers were shown. -, titer of ,1.0 log10 PFU/ml; NA, not available.
cVirus titers of two ferrets, since one of the three ferrets died before day 6.
dVirus titer of one ferret, since two of the three ferrets died before day 6.
eMean maximum changes in body weight and body temperature with standard deviations.
fNo. of animals/total.
doi:10.1371/journal.ppat.1001106.t001
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Although substantial numbers of viral antigen-positive cells were
detected in the lungs of ferrets infected UT3062 or UT3028, the
lungs of ferrets infected with UT3062 had marked infiltration of
eosinophils around/in the bronchi (Figure 3A). By contrast, the
lung lesions of ferrets infected with UT3028 contained many
neutrophils (Figure 3B). Secondly, viral infection in the tracheo-
bronchial (pulmonary regional) lymph node at 1 day p.i. differed
between the two viruses. Although we did not detect viral antigen
in the tracheobronchial lymph node of ferrets infected with
UT3028, we did find viral antigen at this site in all three ferrets
infected with UT3062 (Figure 3D and E). Thirdly, in animals
infected with UT3028, we did not detect viral antigen beyond 3
days p.i., with the exception of one ferret, which was euthanized at
5 days p.i. (Figure 4A). The numerous neutrophils observed on 1
day p.i. were replaced by lymphocytes, macrophages and
regenerative epithelial cells during the course of infection (data
not shown). On the other hand, in animals infected with UT3062,
a substantial number of viral antigen-positive cells were detected in
the lungs even 3 days p.i. and the areas in the lungs where the viral
antigen-positive cells were detected expanded widely by 5 and 7
days p.i. in some ferrets (Figure 4B). Moreover, when compared to
Figure 1. UT3062 differs from UT3028 in its virulence in ferrets. (A) Survival of ferrets infected with 10
7 PFU of UT3062 (n=6) and UT3028
(n=3) is indicated. (B) Percent body weight change of each virus-infected ferret is shown.
doi:10.1371/journal.ppat.1001106.g001
Genetic Basis for High Virulence of H5N1 Virus
PLoS Pathogens | www.plospathogens.org 4 September 2010 | Volume 6 | Issue 9 | e1001106ferret lung lesions with less viral antigen-positive cells, the lesions
of ferrets with extensive viral antigen-positive cells had fewer
lymphocytes and substantial pulmonary edema, hemorrhaging
and fibrinous exudates (data not shown). These findings indicate
that there was a tendency for delay in viral clearance in UT3062-
infected ferrets and consequently some animals progressed to
death. The virus was, however, completely eliminated in some
animals, presumably because of individual animal variability.
Next, to evaluate the effect of the UT3062 HA and NS genes in
vivo, we examined the pathogenicity of 3062(HA+NS) virus,
which possesses UT3062 HA and NS genes and its remaining
genes from UT3028. When we examined ferrets infected with
3062(HA+NS) on days 3 and 7 p.i., we found that they had
pathological lesions that more closely resembled those of ferrets
infected with UT3062 than those of ferrets infected with UT3028.
Namely, the ferrets had viral infection in the tracheobronchial
lymph node and widely distributed viral pneumonia by 3 days p.i.
(Figure 3G to I). Pulmonary edema, hemorrhages and fibrinous
exudates were obvious in the lung lesions rather than recruitment
of lymphocytes and regenerative changes, which were character-
istic of ferrets infected with UT3028.
Therefore, the UT3062 HA and NS gene products play a
critical role in viral pathogenicity in this ferret model. Viruses first
replicated in the lungs (at the primary site of viral exposure), and
infection then expanded into the tracheobronchial lymph node.
Viral infection in the regional lymph node may negatively affect
viral exclusion from the host, leading to continued viral
replication.
Characterization of Reassortant Viruses with Mutations in
Their Glycoproteins
UT3062, like almost all other human H5N1 viruses, has alanine
at position 134 of HA (H3 numbering). UT3028, however, has
threonine at this position (Table 2). These findings suggest that a
single substitution at position 134 (A134T) of HA affects virulence
in ferrets. Previously, Auewarakul et al. [11] showed that
substitutions at positions 129 and 134 (L129V/A134V) allow
virus recognition of both sialic acid liked to galactose by a2,3
linkage (SAa2,3Gal) and SAa2,6Gal, unlike the parent virus,
which recognizes only SAa2,3Gal. Yamada et al. [12], however,
found that a single substitution at position 134 (A134T) did not
change receptor-binding preference with the same sialylglycopo-
lymers used by Auewarakul et al. [11]. We, therefore, performed
Figure 2. The HA and NS genes contribute to virulence in ferrets. Ferrets were infected with 10
7 PFU of reassortant viruses that combine the
genes of UT3062 (red) and UT3028 (white), generated by reverse genetics, and with the parental UT3062 and UT3028 viruses. Lethality, mean
maximum weight change 6 standard deviations (SD), and the number of ferrets used (n) are indicated. Animals with greater than 20% weight loss,
hemorrhage from any body orifice, or inability to remain upright were euthanized. Pol, polymerase complex. HA+NA, surface glycoproteins, HA and
NA.
doi:10.1371/journal.ppat.1001106.g002
Table 2. Amino acid differences between H5N1 influenza
UT3028 and UT3062.
Position UT3062 UT3028
HA
a 134 A T
NS1 200 S N
205 R G
NS2 47 A T
51 I M
aH3 numbering.
doi:10.1371/journal.ppat.1001106.t002
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Viruses Tissues Days p.i.
a
37
Animal No.
D3-1 D3-2 D3-3 D7-1 D7-2 D7-3
UT3028 Brain - - 2.8 - - -
Olfactory Bulb - - - - - -
L u n g --4 . 5 ---
Hilar lymph node - - - - - -
Liver - - - - - -
K i d n e y ------
Spleen - - - - - -
Small Intestine - - - - - -
C o l o n ------
Nasal Swab 3.6 4.0 3.3 - - -
Trachea Swab - - - - - -
UT3062 Brain 3.0 - 3.0 4.3 - 6.2
Olfactory Bulb 3.3 4.8 5.3 5.5 - 6.2
Lung 6.1 5.3 4.0 5.6 - 8.6
Hilar lymph node 4.5 3.5 3.6 3.5 - -
Liver 8.2 6.1 3.7 5.1 - 5.5
Kidney 4.3 2.0 - - - 6.7
Spleen 4.8 3.6 3.5 3.3 - 7.1
Small Intestine 3.2 2.3 - 3.7 - -
Colon 3.0 - - 3.7 - 5.5
Nasal Swab 6.0 3.7 4.8 - - 4.4
Trachea Swab 2.6 1.0 3.6 - - 6.1
3062(HA+NA+NS) Brain 3.2 - 3.1 5.4 5.7 4.6
Olfactory Bulb 4.3 5.0 5.4 5.5 5.4 3.3
Lung 4.6 - 4.5 - 7.3 5.2
Hilar lymph node 4.3 - - - 3.9 2.3
Liver 5.9 - 5.1 5.2 7.3 5.2
Kidney - - - - 4.6 -
Spleen 4.2 3.4 3.3 - 4.6 -
Small Intestine 3.3 - - - 4.2 2.0
Colon - - - 2.0 4.0 -
Nasal Swab 4.5 5.4 4.3 - 5.1 -
Trachea Swab 3.8 2.5 1.7 2.2 5.1 2.5
3062(HA+NS) Brain 5.4 5.7 4.0 9.4 6.4 8.4
Olfactory Bulb 6.6 6.9 6.8 8.1 9.4 9.6
Lung 7.8 5.8 3.4 7.4 6.5 7.2
Hilar lymph node 6.5 3.2 2.7 3.5 5.4 5.4
Liver 8.4 2.8 5.1 6.3 6.3 5.4
Kidney 5.8 - - 3.8 2.3 -
Spleen 6.8 4.6 7.6 5.9 5.4 -
Small Intestine 4.1 - 2.8 5.0 3.4 3.7
Colon 4.5 2.3 - 5.7 2.9 -
Nasal Swab 5.7 4.5 5.0 3.5 3.0 3.2
Trachea Swab 4.5 2.5 4.0 4.9 3.1 4.2
3062(NP+HA+NS) Brain 3.5 4.0 5.8 5.8 8.2 6.7
Olfactory Bulb 4.0 5.7 7.7 5.6 9.4 4.5
Genetic Basis for High Virulence of H5N1 Virus
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chicken erythrocytes, which express both SAa2,3Gal and
SAa2,6Gal [13], UT3062 and a reassortant possessing the
UT3062 HA were not eluted even after 20h of incubation at
37uC. By contrast, UT3028 and a reassortant possessing the
UT3028 HA were gradually released from chicken erythrocytes
(Figure 5). Since the viruses possessing the UT3028 HA were
eluted regardless of the origin of the NAs (either UT3028 or
UT3062), this difference in elution from erythrocytes is due to the
difference in the amino acid residue at position 134 of HA. When
we used horse erythrocytes, all of the viruses were more rapidly
eluted from these erythrocytes than from chicken erythrocytes;
however, UT3028 and a reassortant possessing the UT3028 HA
were eluted more efficiently from horse erythrocytes than were
UT3062 and reassortants possessing the UT3062 HA (data not
shown). These results suggest that UT3062 HA differs from
UT3028 HA in its receptor-binding property.
Interferon Antagonistic Property of Reassortant Viruses
with Mutations in NS Gene
NS1 mediates type I IFN antagonism and affects viral growth in
cells. We, therefore, assessed the IFN antagonistic activity of these
NS1s by using an IFN bioassay [14,15,16,17,18,19,20]. Briefly,
Mv1Lu cells were infected with each virus at an MOI of 1.25 and
the supernatants were collected at 12–24 h p.i. H5N1 viruses in
the supernatants were inactivated with UV and neutralizing
antibody (A1A1, [21]) treatment. The supernatants were added to
fresh Mv1Lu cells and cultured for 22 h, followed by infection with
vesicular stomatitis virus (VSV) to determine VSV infectivity of the
above-described supernatant-pretreated Mv1Lu cells. As a control,
we used a recombinant influenza virus expressing an RNA-
binding- and IFN-antagonism-defective NS1 protein within which
two basic amino acids were substituted to alanines (R38A/K41A)
on the UT3062 backbone [17,22]. We also generated reassortant
viruses possessing the mutant NS1 of UT3028 that has either the
N200S or the G205R mutation, on the UT3028 backbone and
designated them 3028NS1-N200S and 3028NS1-G205R, respec-
tively. As described above, these viruses also possessed amino acid
substitution in NS2, T47A, or M51I, respectively.
At 18 h and 24 h p.i., the supernatant from Mv1Lu cells
infected with UT3028 or a virus possessing the UT3028 NS gene
and the remaining genes from UT3062 (i.e., 3028(NS)) inhibited
VSV plaque formation more efficiently than did the supernatants
from cells infected with UT3062 (statistically significant difference
at P,0.05, Tukey Honestly Significant Difference [HSD] test)
(Figure 6). Furthermore, the supernatant of cells infected with
either 3028NS1-N200S or 3028NS1-G205R inhibited VSV
plaque formation more efficiently than did that from viruses
possessing the UT3062 NS gene (i.e., UT3062 and 3062(NS))
(statistically significant difference, P,0.05, Tukey HSD test), but
less efficiently than that from viruses possessing the UT3028 NS
gene (i.e., UT3028 and 3028(NS)) (Figure 6). These results indicate
that both serine at position 200 and arginine at position 205 of
NS1 contribute to the enhanced type I IFN antagonistic property
of UT3062 NS1, which, in turn, leads to high virulence in ferrets.
To further assess the IFN antagonistic property of NS1, we
investigated the effects of the amino acids in NS1 on the expression
of the firefly luciferase reporter gene under the control of an
interferon-stimulated response element (ISRE) in 293 cells treated
with IFNb. Briefly, 293 cells were transfected with pISRE-Luc,
pRL-TK, and pCAGGS NS1 or pCAGGS GFP (negative
control). At 24 h post-transfection, the cells were treated with
recombinant human IFNb. At 30 h post-transfection, the cells
were lysed and luciferase activities were measured by using the
Dual-luciferase Reporter assay system. There were, however, no
significant differences in expression from the ISRE between
UT3062 NS1 and UT3028 NS1 (data not shown). We then
investigated the effects of the amino acids in NS1 on the expression
of the firefly luciferase reporter gene under the control of the IFNb
promoter in 293 cells treated with Sendai virus (SeV) as described
previously [23]. Briefly, 293 cells were transfected with p125-Luc,
pRL-TK, and pCAGGS NS1 or pCAGGS GFP (negative
control). At 36 h post-transfection, the cells were treated with
SeV (Cantell strain). At 48 h post-transfection, the cells were lysed
and luciferase activities were measured by using the Dual-
luciferase Reporter assay system. The results of this experiment
also showed that there were no significant differences in expression
from the IFNb promoter between UT3062 NS1 and UT3028 NS1
Viruses Tissues Days p.i.
a
37
Animal No.
D3-1 D3-2 D3-3 D7-1 D7-2 D7-3
Lung 5.9 5.7 6.5 7.6 7.0 7.4
Hilar lymph node 4.3 3.5 4.4 6.3 4.0 3.3
Liver 6.4 6.6 4.9 8.2 6.3 6.2
Kidney 3.5 3.3 - 6.7 2.0 2.3
Spleen 4.2 4.7 2.3 6.9 3.3 2.0
Small Intestine - 3.1 4.1 6.8 3.4 -
Colon - 3.1 3.2 6.6 2.5 -
Nasal Swab 4.1 5.4 5.6 5.7 3.9 5.2
Trachea Swab 3.8 2.5 5.0 5.5 3.8 3.2
aTissues were collected from ferrets infected with 10
7 PFU of virus on days 3 and 7 pi. The samples were titrated in MDCK cells. The virus titer was calculated as PFU per
gram (for tissues) or ml (swabs) and expressed as log10 PFU/gram or ml. -, titer of ,2.0 log10 PFU/g or 1.0 log10 PFU/ml.
doi:10.1371/journal.ppat.1001106.t003
Table 3. Cont.
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antagonistic property.
Discussion
Here, using H5N1 viruses isolated from humans, we found that
receptor-binding property and NS1 IFN antagonism play
important roles in the high virulence of these viruses in ferrets.
HA is a receptor-binding and fusion protein and, therefore, is
required for virus entry. It is known to play a critical role in
virulence [4,24,25,26,27]. In this study, we found that viruses
possessing threonine at position 134 of HA were appreciably
attenuated in ferrets compared to those possessing alanine.
Although Yamada et al. [12] did not find differences in the
receptor-binding preference between HAs with a single substitu-
tion at position 134 (134A or 134T) in a direct binding assay to
sialylglycopolymers, we found that this substitution affected
receptor-binding property as detected by a virus elution assay
(Figure 5). Since the amino acid at position 134 is located near the
receptor-binding pocket but does not directly interact with
sialyloligosaccharides [11], the substitution at this residue may
influence the receptor-binding property indirectly. Alanine at
position 134 of HA is highly conserved in avian H5N1 viruses—
only one virus is known to harbor serine at that position (the
Influenza Sequence Database (ISD; https://flu.lanl.gov/, regis-
tration system [28])). Similarly, most human H5N1 viruses also
have alanine at this position; however, UT3028 and two other
H5N1 viruses that we isolated from humans have threonine at this
position (Y. Sakai-Tagawa and Y. Kawaoka, unpublished).
Further, eleven H5N1 viruses isolated from humans have valine
Figure 3. Pathological findings in ferrets infected with UT3062 or 3062(HA+NS). (A) Lungs of ferret infected with UT3062. Infiltration of
eosinophils (arrowheads and insert) was obvious around the bronchi 1 day p.i. (B) Lungs of ferrets infected with UT3028. Neutrophils (arrowheads and
insert) were apparent in the lung lesion 1 day p.i. (C) The bronchial area of normal appearance has clear air spaces. (D) Immunostaining of
tracheobronchial lymph node in a ferret infected with UT3062. Virus antigen can be seen in the sinusoid area (brown pigment) 1 day p.i. (E) Higher
magnification of Figure 3D’s broken-line square area. Reticular cell-like cells in the sinusoid stain positive for virus antigen (brown pigment). (F) The
lymph node with normal appearance did not contain brown pigments. (G) Immunostaining of tracheobronchial lymph node in a ferret infected with
3062(HA+NS). Many viral antigen-positive cells are visible in the sinusoid (brown pigment) 7 days p.i. (H) Lung lesion in a ferret infected with
3062(HA+NS). Prominent inflammatory infiltrates and hemorrhage are detected 7 days p.i. by H&E staining. (I) Immunostaining of Figure 3H lesion.
Heavy staining of virus antigen can be seen in the bronchial epithelium and alveolar cells (brown pigments) 7 days p.i.
doi:10.1371/journal.ppat.1001106.g003
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and Y. Sakai-Tagawa and Y. Kawaoka, unpublished). These data
indicate that an amino acid substitution at position 134 of HA is
more frequently observed in human H5N1 viruses than in avian
viruses, suggesting that viruses possessing a substitution at position
134 of HA may be selected during replication in humans.
Although NS1 is a multifunctional protein, one of its main
functions is to suppress type I IFN production [29]. Recent studies
revealed that NS1 plays an important role(s) in antiviral responses
via dsRNA-dependent protein kinase R (PKR) and 2959-
oligoadenylate synthetase/RNase L [30,31]. Here, using an IFN
bioassay, we showed that both serine at position 200 and arginine
at position 205 of NS1 contribute to the enhanced type I IFN
antagonistic property of UT3062 that leads to high virulence in
ferrets. However, we did not observe significant differences in
IFNb-stimulated expression from the ISRE or in SeV-stimulated
expression from the IFNb promoter in 293 cells between the
UT3062 and UT3028 NS1 proteins. It may be that NS1 exhibits
type I IFN antagonism by a mechanism other than tested in this
study. Alternatively, the difference observed in the highly sensitive
IFN bioassay using VSV is not detectable in other IFN assays. The
amino acid residues at positions 200 and 205 of NS1 are not well
Figure 5. UT3062 and UT3028 differ in their virus elution ability from erythrocyte. Two-fold dilutions of virus containing HA titers of 1:64
were incubated with equal volumes of 0.55% chicken erythrocytes at 4uC for 1 h. They were then incubated at 37uC and the reduction in HA titers
was recorded for 20 h.
doi:10.1371/journal.ppat.1001106.g005
Figure 4. Distribution of lung lesions and viral antigens in ferrets. (A) Lungs of ferrets infected with UT3028. 1, 3, 5, and 7 days p.i. (B) Lungs
of ferrets infected with UT3062. 1, 3, 5, and 7 days p.i. (C) Lungs of ferrets infected with 3062(HA+NS). 3 and 7 days p.i. Viral antigens in lung lesions,
+++; many, ++; moderate, +; few, 6; scant, 2; not detected. Distributions of lung lesions and viral antigens were confirmed by microscopic
examination.
doi:10.1371/journal.ppat.1001106.g004
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have been observed in other human and avian H5N1 viruses
(Table S3). These findings support the hypothesis that the amino
acid residues determined to be important in this study are affected
by the genetic background of the test viruses. Nonetheless, the HA
amino acid at position 134 and the NS1 amino acids at positions
200 and 205 may now be included as virulence markers for H5N1
viruses.
Materials and Methods
Ethics Statement
Our research protocol for the use of ferrets followed the
University of Tokyo’s Regulations for Animal Care and Use,
which was approved by the Animal Experiment Committee of the
Institute of Medical Science, the University of Tokyo (approval
number: 19–29). The committee acknowledged and accepted both
the legal and ethical responsibility for the animals, as specified in
the Fundamental Guidelines for Proper Conduct of Animal
Experiment and Related Activities in Academic Research
Institutions under the jurisdiction of the Ministry of Education,
Culture, Sports, Science and Technology, 2006.
Cells
Madin-Darby canine kidney (MDCK) cells were maintained in
minimal essential medium (MEM) with 5% newborn calf serum.
Human embryonic kidney 293 and 293T cells were maintained in
Dulbecco’s modified Eagle’s MEM (DMEM) with 10% fetal calf
serum. Mink lung epithelial (Mv1Lu) cells were maintained in
MEM with 10% fetal calf serum and 1% non-essential amino
acids. All cells were grown at 37uCi n5 %C O 2.
Viruses
H5N1 viruses isolated from humans in Vietnam and Indonesia
were used in this study (Table 1). Virus stocks were propagated
through two passages in MDCK cells for 24–48 h at 37uC. The
cell supernatants were harvested, clarified by centrifugation,
aliquoted, and stored at 280uC. The frozen virus stocks were
Figure 6. The 3062 NS gene promotes IFN antagonism. Mv1Lu cells were infected with each virus at an MOI of 1.25. Supernatants from virus-
infected cells were harvested 12–24 h p.i. After inactivation of viral infectivity, the supernatants were added to fresh Mv1Lu cells and incubated for
22 h. The pretreated Mv1Lu cells were then infected with VSV and infectivity was assessed by plaque assays. N200S represents the virus expressing
mutant NS1 protein in which asparagine was substituted to serine and mutant NS2 protein in which threonine was substituted to alanine on the
UT3028 backbone. G205R represents the virus expressing mutant NS1 protein in which glycine was substituted to arginine and mutant NS2 in which
methionine was substituted to isoleucine on the UT3028 backbone. As a control, we used a recombinant influenza virus expressing an RNA-binding-
and IFN antagonism-defective NS1 protein within which two basic amino acids were substituted to alanines (R38A/K41A) on the UT3062 backbone.
The data are shown as mean VSV titers (log10 PFU/ml) 6 SD of triplicate values obtained in a single experiment, and are representative of two
independent experiments.
doi:10.1371/journal.ppat.1001106.g006
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assays. Virus titers were calculated as PFU/ml. All experiments
were performed under biosafety level 3+ conditions.
Plasmid-Based Reverse Genetics
Viral RNA was extracted directly from the supernatants of
H5N1 virus-infected MDCK cell cultures with a QIAamp Viral
RNA Mini Kit (Qiagen, http://www1.qiagen.com/). Comple-
mentary DNA was generated by SuperscriptIII (Invitrogen,
http://www.invitrogen.com/) with the universal primers for
influenza A virus genes. The resulting products were PCR-
amplified using PfuUltra High-Fidelity DNA polymerase (STRA-
TAGENE, http://www.stratagene.com/) with specific primers for
each virus gene and cloned into a plasmid under the control of the
human RNA polymerase I (PolI) promoter and the mouse RNA
PolI terminator (PolI plasmids). We altered the NS1 gene sequence
that encodes the RNA-binding site of UT3062 to create the RNA-
binding defective sequence (R38A/K41A) as previously described
[17].
All reassortant viruses and the parental UT3062 and UT3028
viruses were generated by plasmid-based reverse genetics, as
described by Neumann et al. [32]. Briefly, PolI plasmids and
protein expression plasmids were mixed with a transfection
reagent, TransIT 293T (Mirus Bio, http://www.mirusbio.com/);
incubated at room temperature for 15 min; and then added to
293T cells. Transfected cells were incubated in OPTI-MEM I
(Invitrogen) for 48 h. Supernatants containing infectious viruses
were harvested and propagated in MDCK cells at 37uC for 48 h.
The supernatants were harvested, aliquoted, and stored at 280uC.
Ferret Study
We used male ferrets, 5–7 months old (MarshallBioResources,
http://www.marshallbioresources.com/) in this study. All ferrets
were inoculated intranasally with 10
7 PFU of infectious virus in
500 ml of phosphate-buffered saline (PBS) under anesthesia with
ketamine (25 mg/kg) and xylazine (2 mg/kg). Clinical signs, body
weights, and body temperatures were recorded daily for 10 days
post-infections (p.i.). The percent changes in body weights were
calculated by comparing the weights of each ferret at each time
point to its initial weight on day 0. Body temperatures were
measured using a rectal thermometer. Changes in body temper-
ature were calculated by comparing the body temperatures of each
ferret at each time point to its initial body temperature on day 0.
All animals exhibiting more than 20% weight loss, hemorrhage
from any body orifice, or inability to remain upright were
euthanized. Surviving ferrets were euthanized under deep
anesthesia at 3 weeks p.i. On days 3 and 6 p.i., nasal washes
were collected from anesthetized ferrets and titrated for virus
infectivity in MDCK cells by plaque assays.
Ferrets infected with the parental UT3062 and UT3028 and
selected reassortant viruses (Table 3) were euthanized with deep
anesthesia and necropsied on days 3 and 7 p.i. Tissue samples of
the brain, olfactory bulb, lungs, hilar lymph node, liver, kidney,
spleen, duodenum, and descending colon were collected. A
portion of each was stored at 280uC for virus titration and the
rest were preserved in 10% neutral buffered-formalin for
pathological examination. To prepare 10% tissue emulsions,
frozen tissue samples were thawed, weighed, and homogenized in
10 volumes (w/v) of sterile PBS using a multi-beads shocker (Yasui
Kikai, http://www.yasuikikai.co.jp/). After centrifugation of the
samples at 8006 g for 5 min at 4uC, the supernatants were
collected. In addition, swabs from nose and trachea were collected
and suspended in 1 ml of sterile PBS containing 0.3% BSA and
penicillin (200 U/ml). After centrifugation at 8006g for 5 min at
4uC, the supernatants were collected and stored at 280uC. Virus
in nasal washes, swabs and tissue samples was titrated for virus
infectivity in MDCK cells by plaque assays. Virus titer was
expressed as PFU/g for tissue samples and PFU/ml for nasal
washes and swabs. The limitations of virus detection were 10
2.0
PFU/g for tissue samples and 10
1.0 PFU/ml for nasal washes and
swabs. The formalin-fixed tissues were processed for routine
paraffin embedding. The paraffin-embedded tissues were cut into
5 mm thick slices and stained using hematoxylin-and-eosin (H&E).
Additional sections were cut for immunohistological staining with
rabbit polyclonal antibodies against an H5N1 virus (A/Vietnam/
1203/04). Specific antigen-antibody reactions were visualized by
means of 3,39 diaminobenzidine tetrahydrochloride and the Dako
EnVision system (Dako, http://www.dako.jp/). All animal
experiments were approved by the Animal Research Committee
of The University of Tokyo.
Viral Growth Kinetics in Mv1Lu Cells
The reassortant viruses and the parental UT3062 and UT3028
viruses were inoculated into Mv1Lu cell monolayers at an MOI of
0.001 PFU with MEM containing 0.3% bovine serum albumin,
and incubated at 37uC. Cell supernatants were harvested at a
given number of hours p.i. After centrifugation at 1,0006 g for
5 min, samples were titrated for virus infectivity in Mv1Lu cells by
plaque assays.
Virus Elution Assay
The ability of viruses to be eluted from erythrocytes was assessed
as previously described [33,34], with some modifications. Briefly,
virus stocks were diluted serially in calcium saline (0.9 mM CaCl2-
154 mM NaCl in 20 mM borate buffer, pH 7.2) and 50 ml
aliquots were incubated with 50 ml of 0.55% chicken erythrocytes
at 4uC for 1 h in microtiter plates. The plates were then
transferred to 37uC and monitored periodically for 20 h.
IFN Bioassay
Levels of IFN secreted by virus-infected Mv1Lu cells were
assessed as previously described [14,15,16,17,18,19,20], with some
modifications. Briefly, Mv1Lu cells were infected with each virus
at an MOI of 1.25. Supernatants from infected cells were
harvested 12–24 h p.i. To inactivate viral infectivity, the
supernatants were treated with UV light for 20 min and then
mixed with neutralizing a-VN1203HA monoclonal antibodies
(A1A1, [21]). The supernatants were added to fresh Mv1Lu cells
and incubated for 22 h. These pretreated Mv1Lu cells were then
infected with VSV, and the VSV infectivity titers were
determined. As a control, we used a recombinant influenza virus
expressing an RNA-binding- and IFN antagonism-defective NS1
protein within which two basic amino acids were substituted to
alanines (R38A/K41A). The experiments were carried out in
triplicate and were independently repeated twice.
IFN Reporter Assay
8610
4 of 293 cells were transfected with 50 ng of pISRE-Luc
(Clontech, http://www.clontech.com/) and 50 ng of pRL-TK
(Promega, http://www.promega.com/) by using TransIT293
(Mirus, http://www.mirusbio.com/). 100 ng of pCAGGS NS1
or pCAGGS GFP were co-transfected. Cells were incubated for
24 h and were treated with 100 units of recombinant human
IFNb, 1a (PBL interferonSource, http://www.interferonsource.
com/). At 30 h post-transfection, cells were lysed and luciferase
activities were measured by using the Dual-luciferase Reporter
assay system (Promega, http://www.promega.com/) according to
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values were divided by Renilla luciferase values to normalize for
transfection efficiency.
2610
5 of 293 cells were transfected with 250 ng of p125-Luc
(the reporter plasmid carrying the firefly luciferase gene under the
control of the IFNb promoter was kindly provided by Takashi
Fujita) and 250 ng of pRL-TK (Promega, http://www.promega.
com/) by using TransIT293 (Mirus, http://www.mirusbio.com/).
5–500 ng of pCAGGS NS1 or pCAGGS GFP were co-
transfected. After incubation for 24 h, cells were stripped with
trypsin and divided into two wells of a 12-well plate. At 36 h post-
transfection, cells were treated with approximately 5610
10 focus-
forming unit of SeV (Cantell strain). At 48 h post-transfection,
cells were lysed and luciferase activities were measured by using
the Dual-luciferase Reporter assay system (Promega, http://www.
promega.com/) according to the protocol provided by the
manufacturer. Firefly luciferase values were divided by Renilla
luciferase values to normalize for transfection efficiency.
Supporting Information
Figure S1 Viral growth kinetics in Mv1Lu cells. The reassortant
viruses and the parental UT3062 and UT3028 viruses were
infected into Mv1Lu cell at an MOI of 0.001 PFU. The viruses in
the cell supernatants were harvested at a given number of hours
p.i. and titrated in Mv1Lu cells. Values are the means 6 SD of
three independent experiments. No appreciable differences were
observed in their replication properties in Mv1lu cells.
Found at: doi:10.1371/journal.ppat.1001106.s001 (0.21 MB TIF)
Table S1 Virus replication in the respiratory tract and other
tissues of ferrets fatally infected with H5N1 virus.
Found at: doi:10.1371/journal.ppat.1001106.s002 (0.04 MB
DOC)
Table S2 Amino acid differences between UT3028 and
UT3062.
Found at: doi:10.1371/journal.ppat.1001106.s003 (0.05 MB
DOC)
Table S3 Amino acids at positions 200 and 205 of NS1 in
human and avian H5N1 viruses.
Found at: doi:10.1371/journal.ppat.1001106.s004 (0.04 MB
DOC)
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